Related Experiment Video

Updated: Jul 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Role of mitogen-activated protein kinase kinase 4 in cancer

A J Whitmarsh1, R J Davis

  • 1Faculty of Life Sciences, University of Manchester, Manchester, UK.

Oncogene
|May 15, 2007
PubMed

Insights

Mitogen-activated protein kinase kinase 4 (MKK4) regulates stress responses and embryonic development. Its role in cancer is complex, potentially acting as both a tumor suppressor and promoter.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Biology

Background:

  • Mitogen-activated protein (MAP) kinase kinase 4 (MKK4) is a key regulator in stress-activated signaling pathways.
  • MKK4 activates c-Jun N-terminal kinase (JNK) and p38 MAP kinases in response to various cellular stimuli.
  • MKK4 plays crucial roles in embryonic development, immune function, and cardiac health.

Purpose of the Study:

  • To review the biochemical and functional properties of MKK4.
  • To discuss the multifaceted role of MKK4 in cancer development.
  • To explore potential mechanisms of MKK4 in tumorigenesis and metastasis.

Main Methods:

  • Literature review of biochemical and functional studies on MKK4.
  • Analysis of genetic data linking MKK4 mutations to cancer.
  • Integration of findings from in vivo and in vitro studies.

Main Results:

  • MKK4 is essential for embryonic viability and involved in multiple physiological processes.
  • Loss-of-function mutations in MKK4 are observed in various human cancers, suggesting tumor suppressor activity.
  • MKK4 has been identified as a suppressor of metastasis in prostate and ovarian cancers.
  • Conflicting evidence suggests MKK4 may also promote oncogenesis in certain contexts.

Conclusions:

  • MKK4 exhibits complex roles in cancer, acting as both a suppressor and potentially a promoter.
  • Understanding MKK4's dual role is critical for developing targeted cancer therapies.
  • Further research is needed to elucidate the precise mechanisms governing MKK4's function in tumorigenesis.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...